Within the context of IBD, aberrant activation and dysregulation of NF-κB have been identified as significant contributors to the pathogenesis of these conditions, and inhibition of NF-κB has been associated with alleviation of IBD occurrence (Laurindo et al. 2023; Rogler et al. 1998). This evidence concerns the gene NFKB1 and inflammatory bowel disease.